Shu Ling Chiang

68 year

Health Technology

Consumer Services

Profile

Shu Ling Chiang is currently the Chairman of BioFirst Corp., a Director at ABVC BioPharma, Inc., the Managing Director at Biokey, Inc., and a Director at BioLite, Inc. She has a graduate degree from Northwestern University and an undergraduate degree from National Taiwan Normal University.

Shu Ling Chiang active positions

Companies	Position	Start
BIOFIRST CORP	Chairman	2007-09-09
ABVC BIOPHARMA, INC.	Director/Board Member	-
BioLite, Inc. /Taiwan/ BioLite, Inc. /Taiwan/ Pharmaceuticals: GenericHealth Technology Founded in 1995, BioLite, Inc. /Taiwan/ is a Taiwanese company that specializes in advanced biomedical technology. Part of ABVC BioPharma, Inc., the private company is based in Taipei, Taiwan. The description of the company is "????????????", which translates to "Lite Advanced Biomedical Co., Ltd." in English. BioLite, Inc. /Taiwan was acquired by ABVC BioPharma, Inc. on December 31, 2022.	Director/Board Member	-
Biokey, Inc. Biokey, Inc. Pharmaceuticals: GenericHealth Technology Biokey, Inc. develops and markets generic drugs. Its services include regulatory support, analytical services, product development, and GMP manufacturing. The company was founded by George J. Lee in 2001 and is headquartered in Fremont, CA.	Corporate Officer/Principal	2021-12-31

All active positions of Shu Ling Chiang

Training of Shu Ling Chiang

National Taiwan Normal University	Undergraduate Degree
Northwestern University	Graduate Degree

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Shu Ling Chiang's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Listed companies	1
ABVC BIOPHARMA, INC.	Health Technology

Private companies	3
BioFirst Corp. BioFirst Corp. BiotechnologyHealth Technology BioFirst Corp. engages in the research and development, manufacture and sale of medical equipment and medicines. Its products include testing equipment and reagents, vitreous filler, and Nano drug carriers. The company is the agent of Infopia's Clover AlcSelf glycosylated hemoglobin real time detection system, Infopia's GluKoPetA1c animal hemoglobin detection system, and BioPredictive's FibroTest and FibroMax liver fibrosis assessment tools. The company was founded on November 7, 2006 and is headquartered in Taipei, Taiwan.	Health Technology
BioLite, Inc. /Taiwan/ BioLite, Inc. /Taiwan/ Pharmaceuticals: GenericHealth Technology Founded in 1995, BioLite, Inc. /Taiwan/ is a Taiwanese company that specializes in advanced biomedical technology. Part of ABVC BioPharma, Inc., the private company is based in Taipei, Taiwan. The description of the company is "????????????", which translates to "Lite Advanced Biomedical Co., Ltd." in English. BioLite, Inc. /Taiwan was acquired by ABVC BioPharma, Inc. on December 31, 2022.	Health Technology
Biokey, Inc. Biokey, Inc. Pharmaceuticals: GenericHealth Technology Biokey, Inc. develops and markets generic drugs. Its services include regulatory support, analytical services, product development, and GMP manufacturing. The company was founded by George J. Lee in 2001 and is headquartered in Fremont, CA.	Health Technology

See company connections

Stock Market
Insiders
Shu Ling Chiang